Literature DB >> 21734451

Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53.

Hwan Ki Park1, Jayabal Panneerselvam, Fred Duafalia Dudimah, Guangzhi Dong, Sinto Sebastian, Jun Zhang, Peiwen Fei.   

Abstract

Wip1, a human protein Ser/Thr phosphatase also called PPM1D, stands for wild type p53 induced phosphatase 1. Emerging evidences indicate that Wip1 can act as an oncogene largely by turning off DNA damage checkpoint responses. Here we report an unrecognized role of Wipl in normally growing cells. Wip1 can be induced by wild type p53 under not only stressed but also non-stressed conditions. It can trigger G 2/M arrest in wild type p53 containing cells, which was attributed to the decreased Cdc2 kinase activity resulting at least partly from a high level of inhibitory tyrosine phosphorylation on Cdc2 protein at Tyr-15. Furthermore, we also found that Wip1 not only causes G 2/M arrest but also decreases cell death triggered by microtubule assembly inhibitor in mouse fibroblasts when wild type p53 function was restored. These results indicate that Wip1 can provide ample time for wild type p53-containing cells to prepare entry into mitosis and avoid encountering mitotic catastrophe. Therefore, Wipl may play important roles in cell/tissue homeostasis maintained by wild type p53 under normal conditions, enhancing our understanding of how p53 makes cell-fate decisions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734451      PMCID: PMC3180196          DOI: 10.4161/cc.10.15.15923

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  66 in total

Review 1.  The p53 response element and transcriptional repression.

Authors:  Bei Wang; Ziwei Xiao; Hui Ling Ko; Ee Chee Ren
Journal:  Cell Cycle       Date:  2010-03-02       Impact factor: 4.534

2.  Fine-tuning the DNA damage response: protein phosphatase 2A checks on CHK2.

Authors:  Marcus Smolka
Journal:  Cell Cycle       Date:  2010-03-01       Impact factor: 4.534

Review 3.  Genomic instability--an evolving hallmark of cancer.

Authors:  Simona Negrini; Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

Review 4.  The p53 pathway as a target in cancer therapeutics: obstacles and promise.

Authors:  Anna Mandinova; Sam W Lee
Journal:  Sci Transl Med       Date:  2011-01-05       Impact factor: 17.956

Review 5.  Role of the p53 family in stabilizing the genome and preventing polyploidization.

Authors:  Flaminia Talos; Ute M Moll
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 6.  Protein phosphatase 1 regulators in DNA damage signaling.

Authors:  Thomas Küntziger; Helga B Landsverk; Philippe Collas; Randi G Syljuåsen
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

7.  FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth.

Authors:  Jun Zhang; Deping Zhao; Hwan Ki Park; Hong Wang; Roy B Dyer; Wanguo Liu; George G Klee; Mark A McNiven; Donald J Tindall; Julian R Molina; Peiwen Fei
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

8.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

Review 9.  WIP1 phosphatase at the crossroads of cancer and aging.

Authors:  Xavier Le Guezennec; Dmitry V Bulavin
Journal:  Trends Biochem Sci       Date:  2009-10-29       Impact factor: 13.807

Review 10.  p53 as the main traffic controller of the cell signaling network.

Authors:  Sinto Sebastian; Amalia Azzariti; Nicola Silvestris; Letizia Porcelli; Antonio Russo; Angelo Paradiso
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01
View more
  8 in total

1.  Integrative Proteomic and Phosphoproteomic Profiling of Testis from Wip1 Phosphatase-Knockout Mice: Insights into Mechanisms of Reduced Fertility.

Authors:  Yinghui Wei; Qian Gao; Pengxia Niu; Kui Xu; Yiqing Qiu; Yanqing Hu; Shasha Liu; Xue Zhang; Miaoying Yu; Zhiguo Liu; Bingyuan Wang; Yulian Mu; Kui Li
Journal:  Mol Cell Proteomics       Date:  2018-10-25       Impact factor: 5.911

2.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

Review 3.  Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.

Authors:  Ahmed Y Ali; Lee Farrand; Ji Young Kim; Sanguine Byun; Jeong-Yong Suh; Hyong Joo Lee; Benjamin K Tsang
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

4.  FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.

Authors:  Jayabal Panneerselvam; Hwan Ki Park; Jun Zhang; Fred Duafalia Dudimah; Piyan Zhang; Hong Wang; Peiwen Fei
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

5.  Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation.

Authors:  J-Y Song; S-H Ryu; Y M Cho; Y S Kim; B-M Lee; S-W Lee; J Choi
Journal:  Cell Death Dis       Date:  2013-08-01       Impact factor: 8.469

6.  Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway.

Authors:  Ping Wang; Jiayue Cui; Jihong Wen; Yunhui Guo; Liangzi Zhang; Xia Chen
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

7.  Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development.

Authors:  B Han; H K Park; T Ching; J Panneerselvam; H Wang; Y Shen; J Zhang; L Li; R Che; L Garmire; P Fei
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

8.  A hidden role of the inactivated FANCD2: upregulating ΔNp63.

Authors:  Jayabal Panneerselvam; Anna Pickering; Jun Zhang; Hong Wang; Hui Tian; Junnian Zheng; Peiwen Fei
Journal:  Oncotarget       Date:  2013-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.